Deals Of The Week: Amgen/Micromet, Celgene/Avila, Watson/Ascent
By
Joseph Haas, Jessica Merrill, Lisa LaMotta, Paul Bonanos, Melanie Senior, Wendy Diller / Email the Authors / “The Pink Sheet” Jan. 30, 2012, Vol. 74, No. 5
Business & Finance / Word Count: 2497 / Article # 00120130010
Executive Summary
Along with three biotech acquisitions, the week in deal-making also saw the licensing of a new hepatitis C candidate with a different mechanism of action, further consolidation in the animal health field, and the end of Ipsen and Santhera’s collaboration on Alzheimer’s drug fipamezole.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.